Acea Therapeutics Inc
Acea Therapeutics Inc, located in San Diego, California, is a wholly owned subsidiary of Sorrento Therapeutics, dedicated to developing and delivering innovative treatments for patients with life-threatening diseases. The company's lead compound, Abivertinib, is currently under review by the China Food and Drug Administration for the treatment of non-small cell lung cancer and is also involved in clinical trials for hospitalized COVID-19 patients in Brazil and the U.S.
In addition to its research and development efforts, Acea Therapeutics has established drug manufacturing and commercial capabilities in China to support long-term growth. This infrastructure enhances the company's control over its supply chain, ensuring timely delivery of products to patients.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.